Implicación de alopurinol y rofecoxib en agranulocitosis y necrosis tubular aguda

Real Panisello, M; Vila Clérigues, N; García Reina, L; Luaces Vidal, F; González Ponce, C. M; Díaz Carrasco, M. S.
Farm. hosp ; 27(5): 317-322, sept. 2003.
Artículo en Es | IBECS (España) | ID: ibc-25278

Documentos relacionados

  1. [Role of allopurinol and rofecoxib in agranulocytosis and acute tubular necrosis].
  2. Reply to: "Lack of evidence for a continuum between hepatorenal syndrome and acute tubular necrosis".
  3. Vitamin C Deficiency Causes Cell Type-Specific Epigenetic Reprogramming and Acute Tubular Necrosis in a Mouse Model.
  4. Distinct developmental reprogramming footprint of macrophages during acute kidney injury across species.
  5. Lack of evidence for a continuum between hepatorenal syndrome and acute tubular necrosis.
  6. [Therapeutics for acute tubular necrosis in 2020].
  7. Mind the Cast: FENa versus Microscopy in AKI.
  8. Oral acyclovir induced hypokalemia and acute tubular necrosis a case report.
  9. Overexpression of Intrarenal Renin-Angiotensin System in Human Acute Tubular Necrosis.
  10. Histopathological kidney changes and myoglobinuria in neotropical non-human primates attacked by dogs, Brazil.